Compliance & Validation — Documented
ISO 27001
Deep Genomics
AI-powered genetic medicine company discovering and developing RNA-targeting therapies.
Deep Genomics has built an AI platform called the Big SOI (System of Intelligence) that identifies genetic variants and their biological consequences at genome-wide scale. The platform predicts RNA splicing outcomes and guides the design of RNA-based medicines, with a pipeline focused on rare genetic diseases.
- Headquarters
- Toronto, Canada
- Founded
- 2014
- Compliance
- ISO 27001
- Deployment options
- cloud
- Website
- https://www.deepgenomics.com
- https://www.linkedin.com/company/deep-genomics
Categories
AI Use Cases
- Target Identification & Validation
Vendor Scorecard
100% — Complete coverage. Coverage score — how completely Atlas documents Deep Genomics across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Documented
Partnership / milestone based
Implementation & Onboarding — Documented
12+ months
Organization & Role Fit — Documented
Biotech Startup, Mid-Size Biotech, Drug Discovery, R&D Leadership
Solution Scope — Documented
Biomarker Discovery, Target Identification
Company Viability — Documented
Series C, $236M raised, 120+ employees, Founded 2014
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- What RNA targets has the Big SOI system been validated on?
- How do you handle proprietary genomics data confidentiality?
- What wet-lab infrastructure is required to partner?